China’s New Guidelines On Foreign Investment Loosens Restrictions On Drug Distribution
This article was originally published in The Pink Sheet Daily
Executive Summary
A revised investment rule could open new opportunities in China’s enormous pharmaceutical distribution business. The sector, which has already embraced U.S. giant Cardinal Health and the UK’s Alliance Boots, is set for a major consolidation in coming years.